SsIR antigen vaccine (NIAID/Thomas Jefferson University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSsIR antigen vaccine (NIAID/Thomas Jefferson University)
Drug Alias NameStrongyloides stercoralis immunoreactive antigen vaccine (NIAID/Thomas Jefferson University)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNematode Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthThomas Jefferson UniversityNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsNematode Infections

Other Information

ATC CodeN/A
Related LinksN/A